New hope for tough lymphomas: experimental drug targets resistant cancers

NCT ID NCT04842877

First seen Feb 23, 2026 · Last updated May 13, 2026 · Updated 13 times

Summary

This study tests an experimental drug called valemetostat tosylate in 141 people with B-cell lymphoma that has returned or not responded to prior therapy. The drug is a pill taken by mouth that aims to shrink tumors. Researchers are checking how well it works and how safe it is across six different lymphoma types.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA, B-CELL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • A.Z. Sint Jan AV

    Bruges, 8000, Belgium

  • CH Tourelle Peltzer

    Verviers, 4800, Belgium

  • CH d'Avignon

    Avignon, 84000, France

  • CH de la Côte Basque

    Bayonne, 64109, France

  • CHU Hôtel Dieu

    Nantes, 44093, France

  • CHU Mont-Godinne

    Yvoir, Belgium

  • CHU Pontchaillou

    Rennes, 35003, France

  • CHU d'Estaing

    Clermont-Ferrand, 63000, France

  • CHU de Dijon

    Dijon, 21034, France

  • CHU de Montpellier

    Montpellier, 34295, France

  • Ch Metropole Savoie - Site Chambery

    Chambéry, 73000, France

  • Ch de Bretagne Atlantique -

    Vannes, 56017, France

  • Chd de Vendee

    La Roche-sur-Yon, 85925, France

  • Clinique Victor Hugo

    Le Mans, 72000, France

  • Emmanuel Bachy

    Pierre-Bénite, 69495, France

  • François Lemonnier

    Créteil, 94010, France

  • Gh Region Mulhouse Et Sud Alsace

    Mulhouse, 68070, France

  • Institut Bergonié

    Bordeaux, 33076, France

  • Institut Paoli Calmette

    Marseille, 13273, France

  • Institut d'Hématologie de Basse Normandie

    Caen, 14076, France

  • Service des Maladies du Sang - CHRU de Lille

    Lille, 59037, France

  • University Hospital Gent

    Ghent, 9000, Belgium

Conditions

Explore the condition pages connected to this study.